Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-422,814
Closed -$3.88M 22
2025
Q1
$3.88M Buy
422,814
+1
+0% +$6 2.59% 14
2024
Q4
$2.82M Buy
+422,813
New +$3.72M 1.52% 16

Acorn Capital Advisors's OPTN Position: Q2 2025 in Review

Acorn Capital Advisors sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 422,814 shares — an estimated $3.88M sold.

Acorn Capital Advisors first reported a position in OPTN in Q4 2024 and held it in 2 quarters. The position peaked at $3.88M in Q1 2025. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.

  • Acorn Capital Advisors reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
  • Acorn Capital Advisors sold 422,814 OptiNose shares in Q2 2025, an estimated $3.88M.
  • Acorn Capital Advisors first reported a position in OptiNose in Q4 2024 and held it in 2 quarters.
  • Acorn Capital Advisors's OptiNose position peaked at $3.88M in Q1 2025.
  • 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.

Based on Acorn Capital Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.